Liver Disease

Liver Disease :

Mass cytometry technology provides immune monitoring in liver diseases research such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and alcoholic liver disease (ALD). From whole blood samples or PBMCs, mass cytometry enables us to perform deep immune profiling, changes in inflammatory, and biomarker discovery, as well as newly designed NAFLD drug development.

· Immune profiling

· Changes in inflammatory or immune function

· Biomarker discovery of liver diseases using mass cytometry

· Early diagnostic modeling


Mass Cytometry Study on Hepatic Fibrosis and Its Drug-Induced Recovery Using Mouse Peripheral Blood Mononuclear Cells

Bae et al. (2022) Front. Immunol., |

#MassCytometry #LiverDisease #PBMC #ImmuneResponse